TYK Medicines, Inc. (the “Company”) (02410) reported no changes to its registered H share capital and unlisted share capital for the month ended 31 October 2025. The registered H share capital remained at 375,457,818 H shares, and the unlisted share capital stood at 4,608,000 shares. The total registered share capital was RMB 380,065,818, with all share figures carrying a par value of RMB 1 each.

The number of issued H shares and unlisted shares remained unchanged, reflecting 375,457,818 H shares and 4,608,000 unlisted shares respectively. The report indicated no outstanding share options, warrants, convertibles, or other arrangements to issue additional shares.

The information was filed and confirmed by the Company’s Executive Director, Chairman, and Chief Executive Officer on 04 November 2025, highlighting that the concept of “authorized share capital” does not apply under Chinese incorporation practices, and that the data provided refers to officially registered share capital.